P2 | % + ve (95% CI) | Crude OR (95% CI) | Adjusted ORa (95% CI) | ||||
Urethra -ve | Urethra +ve | Total | |||||
P1 | Urethra -ve | 926 | 31 | 957 | 3.2% (2.2 to 4.6) | Ref | Ref |
Urethra +ve | 31 | 2 | 33 | 6.1% (0.7 to 20.2) | 1.9 | 0.3 | |
Total | 957 | 33 | 990 | 3.3% (2.3 to 4.6) | (0.4 to 8.4) | (0.1 to 1.8) | |
P2 | % + ve (95% CI) | Crude OR (95% CI) | Adjusted ORa (95% CI) | ||||
Pharynx -ve | Pharynx +ve | Total | |||||
P1 | Urethra -ve | 942 | 15 | 957 | 1.6% (0.9 to 2.6) | Ref | Ref |
Urethra +ve | 22 | 11 | 33 | 33.3% (18.0 to 51.8) | 31.4*** | 4.6* | |
Total | 964 | 26 | 990 | 2.6% (1.7 to 3.8) | (13.0 to 76.1) | (1.2 to 17.1) | |
P2 | % + ve (95% CI) | Crude OR (95% CI) | Adjusted ORa (95% CI) | ||||
Rectum -ve | Rectum +ve | Total | |||||
P1 | Urethra -ve | 931 | 26 | 957 | 2.7% (1.8 to 4.0) | Ref | Ref |
Urethra +ve | 11 | 22 | 33 | 66.7% (48.2 to 82.0) | 71.6*** | 48.1*** | |
Total | 942 | 48 | 990 | 4.8% (3.6 to 6.4) | (31.5 to 162.9) | (18.3 to 126.7) |